How to read: Every bubble is one Indian irbesartan exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Irbesartan report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial irbesartan trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian irbesartan suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Irbesartan India trade report
P
Product scope
Irbesartan
All variants merged — branded and generic formulations of irbesartan
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
184
Every commercial irbesartan trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a mixed: Oct $1.2M, Nov $2.6M, Dec $847.0K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$1.2M
Oct USD
52 shipments
2
$2.6M
Nov USD
+111.5% MoM
3
$847.0K
Dec USD
-66.8% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 111.5% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $1.2M, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MACLEODS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import irbesartan from India, how much they buy, and who supplies each market
KEY TAKEAWAYGuatemala absorbs 17.7% of India’s 2025-Q4 irbesartan trade ($813.0K). Beyond the top 10 destinations, 36 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Americas has 12 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 36 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much irbesartan India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$785K
17.1% of trade
9 countries · 44 shipments
Europe
$1.1M
23.5% of trade
7 countries · 55 shipments
Americas
$1.9M
41.7% of trade
12 countries · 56 shipments
Africa
$151K
3.3% of trade
7 countries · 12 shipments
Oceania
$668K
14.5% of trade
1 countries · 17 shipments
Fig 4.1 Guatemala is the #1 corridor ($813K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian irbesartan it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Guatemala
$813K
11
CAPLIN POINT LABORATORIES LTD
$813K
—
—
—
—
2
France
$709K
22
MYLAN LABORATORIES LTD
$421K
AUROBINDO PHARMA LTD
$165K
ZYDUS LIFESCIENCES LTD
$123K
3
Australia
$668K
17
ALEMBIC PHARMACEUTICALS LTD
$668K
—
—
—
—
4
Philippines
$463K
14
INTAS PHARMACEUTICALS LTD
$272K
ZYDUS LIFESCIENCES LTD
$168K
COOPER PHARMA LTD
$23K
5
Canada
$366K
8
MACLEODS PHARMACEUTICALS LTD
$293K
SUN PHARMACEUTICAL INDUSTRIES LTD
$73K
—
—
6
El Salvador
$220K
1
SYNERGENE ACTIVE INGREDIENTS PVT LTD
$220K
—
—
—
—
7
United States
$198K
9
MACLEODS PHARMACEUTICALS LTD
$182K
ALEMBIC PHARMACEUTICALS LTD
$16K
—
—
8
Dominican Republic
$170K
9
MEPRO PHARMACEUTICALS PVT LTD
$170K
—
—
—
—
9
Vietnam
$155K
6
ZYDUS LIFESCIENCES LTD
$155K
—
—
—
—
10
United Kingdom
$143K
4
FLAMINGO PHARMACEUTICALS LTD
$84K
JUBILANT GENERICS LTD
$59K
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 17.1% of USD — but Guatemala is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
17.7%
#1 country share
Guatemala alone
65.5%
Top 5 share
5 of 36 countries
94.2%
Top 15 share
Long tail of 21 countries = 5.8%
HHI 1022
Destination HHI
Competitive spread
36
Countries served
Global pharma reach from India
12
Americas countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
33 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYCAPLIN POINT LABORATORIES LTD ($813.0K, 17.7% share) and ALEMBIC PHARMACEUTICALS LTD ($684.0K) together control 32.5% of India’s 2025-Q4 irbesartan trade. The top 5 suppliers hold 66.7%. 33 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian irbesartan suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CAPLIN POINT LABORATORIES LTD leads by $129K over ALEMBIC PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SYNERGENE ACTIVE INGREDIENTS is #9 by value but #18 by volume.
Fig 5.2 ZYDUS LIFESCIENCES LTD also leads by shipment count (30) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SYNERGENE ACTIVE INGREDIENTS moves from #18 by volume to #9 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 33 irbesartan suppliers split into strategic segments
KEY TAKEAWAY9 suppliers (25%) generate 89.0% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CAPLIN POINT LABORATORIES LTD and ALEMBIC PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 89.0% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 4 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
49 importers across 36 countries — who is buying Indian irbesartan and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 72.0% of total USD. 96% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian irbesartan. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 NUEVOS ETICOS NEOETHICALS, S.A is the #1 importer at $453K (9.8%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian irbesartan prices vary by supplier, country and dosage form
KEY TAKEAWAYIrbesartan prices span 158361× ($0.0003 → $54.88). The coefficient of variation is 2.92. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CAPLIN POINT LABORATORIESSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ZYDUS LIFESCIENCES LTDSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. FLAMINGO PHARMACEUTICALS LTDSourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. SYNERGENE ACTIVE INGREDIENTSSourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
ICON PHARMA
DR Congo
Injection
11
$2K
$139.45
Sterile formulation premium
Oct 2025
SYNERGENE ACTIVE…
El Salvador
Tablet
4K
$220K
$54.88
Specialty / small-batch
Dec 2025
AANYA GLOBAL
British Virgin Islands
Tablet
6
$160.75
$26.79
Specialty / small-batch
Nov 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
183
$2K
$12.73
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
2K
$22K
$12.63
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
960
$12K
$12.63
Specialty / small-batch
Oct 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
960
$12K
$12.63
Specialty / small-batch
Nov 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
1K
$18K
$12.63
Specialty / small-batch
Nov 2025
ZYDUS LIFESCIENC…
Sri Lanka
Tablet
2K
$30K
$12.49
Specialty / small-batch
Dec 2025
AANYA GLOBAL
British Virgin Islands
Tablet
44
$489.23
$11.12
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Oct 2025
MICRO LABS LTD
Russia
Tablet
780
$1.00
$0.0013
Bulk generic tablet
Oct 2025
MICRO LABS LTD
Russia
Pack
672
$1.00
$0.0015
Small sample / trial shipment
Dec 2025
CENTURION LABORA…
Philippines
Tablet
10K
$92.16
$0.0092
Bulk generic tablet
Oct 2025
AUROBINDO PHARMA…
Malta
Tablet
2K
$18.40
$0.0096
Bulk generic tablet
Dec 2025
MACLEODS PHARMAC…
Poland
Tablet
865K
$12K
$0.014
Oct 2025
MACLEODS PHARMAC…
United States
Tablet
982K
$15K
$0.015
Dec 2025
MACLEODS PHARMAC…
United States
Tablet
778K
$12K
$0.015
Dec 2025
MACLEODS PHARMAC…
United States
Tablet
778K
$12K
$0.015
Dec 2025
AUROBINDO PHARMA…
Malta
Tablet
388K
$6K
$0.015
Dec 2025
AUROBINDO PHARMA…
Malta
Tablet
388K
$6K
$0.015
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship irbesartan, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYIrbesartan leaves India through 17+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), KATTUPALLI PORT SEA, MUMBAI AIR (SAHAR)) handle 78.1% of total USD. SEA moves 49% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.9M — top 17 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 49% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$2.9M
62.3% of USD · 48.9% of ships
AIR
$1.1M
24.1% of USD · 37.0% of ships
ICD
$600K
13.0% of USD · 13.6% of ships
ROAD
$28K
0.6% of USD · 0.5% of ships
Fig 8.3 The dominant corridor is KATTUPALLI PORT SEA → Sea → N. America ($670K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYMalta is the most concentrated destination (HHI 10000, 1 suppliers). Venezuela is the most competitive (HHI 4352).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Malta (HHI 10,000) is the most concentrated — Venezuela (HHI 4,352) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
NUEVOS ETICOS NEOETH…
Guatemala
CAPLIN POINT LAB…
$453K
6
HIGH
FARMA SOLUTION SOCIE…
Guatemala
CAPLIN POINT LAB…
$360K
5
HIGH
APOTEX PTY LTD
Australia
ALEMBIC PHARMACE…
$311K
11
HIGH
JAMP PHARMA CORP
Canada
MACLEODS PHARMAC…
$293K
6
HIGH
ARROW PHARMACEUTICAL…
Australia
ALEMBIC PHARMACE…
$286K
5
HIGH
R.J. CHEMICALS INC
El Salvador
SYNERGENE ACTIVE…
$220K
1
HIGH
MACLEODS PHARMA USA …
United States
MACLEODS PHARMAC…
$182K
8
HIGH
PHARMACEUTICAL TECHN…
Dominican Republic
MEPRO PHARMACEUT…
$152K
8
HIGH
Conclusion: 47 buyers depend on exactly one Indian supplier, representing $3.5M in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Guatemala
Tier 3 (emerging)
14–28 days (sea)
$0.10–$1/unit
LOW
First-mover advantage
France
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Australia
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Canada
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
El Salvador
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
United States
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Dominican Republic
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
United Kingdom
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Malta
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Kenya
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
Belgium
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Nicaragua
Tier 3 (emerging)
14–28 days (sea)
$1–$10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Guatemala
This Q
HIGH
A2
Offer alternative to top multi-source buyer
This Q
HIGH
A3
Audit Malta lock-ins (HHI 10000)
This Q
MED
A5
Enter Australia (1 suppliers)
This Q
HIGH
A6
Enter Guatemala (1 suppliers)
This Q
MED
A8
Build France distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Australia
Other
1
$668K
+75.5%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
2
Guatemala
Other
1
$813K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
3
France
Other
3
$709K
-70.2%
LOW
Low competition (3 suppliers), accessible market
4
Philippines
Asia
5
$463K
0%
LOW
Low competition (5 suppliers), accessible market
5
Canada
Other
2
$366K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
6
El Salvador
Other
1
$220K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
7
United States
Other
2
$198K
-14.6%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
8
Dominican Republic
Other
1
$170K
-88.2%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
9
Vietnam
Asia
1
$155K
-49.1%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
10
United Kingdom
Other
2
$143K
-100%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
11
Sri Lanka
Asia
1
$112K
-99.5%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Malta
Other
1
$111K
-4.9%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Kenya
Africa
1
$97K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Belgium
Other
1
$58K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Nicaragua
Other
1
$56K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
This report covers 184 2025-Q4 Irbesartan shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/irbesartan
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 184 2025-Q4 irbesartan shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian irbesartan shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
184
across all regions
TOTAL USD
$4.61M
2025-Q4 FOB value
UNITS
74.3M
tablets, capsules, etc.
SUPPLIERS
33
Indian exporters
BUYERS
49
global importers
COUNTRIES
36
destinations
§10.2 Regional breakdown
Africa
$151K
3.3%
7 ctry · 12 ships
Asia
$785K
17.1%
9 ctry · 44 ships
Europe
$1.08M
23.5%
7 ctry · 55 ships
Americas
$1.92M
41.7%
12 ctry · 56 ships
Oceania
$668K
14.5%
1 ctry · 17 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $151K (3.3%), spanning 7 countries.
🏢
33 Indian suppliers shipped to 49 buyers across 36 countries — average shipment value $25K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 47 global irbesartan importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian irbesartan in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
NUEVOS ETICOS NEOETHICALS, S.A
Guatemala
6
$453K
CAPLIN POINT LABORAT…
Tablet
2
FARMA SOLUTION SOCIEDAD ANONIMA
Guatemala
5
$360K
CAPLIN POINT LABORAT…
Tablet
3
APOTEX PTY LTD
Australia
11
$311K
ALEMBIC PHARMACEUTIC…
Tablet
4
JAMP PHARMA CORP
Canada
6
$293K
MACLEODS PHARMACEUTI…
Tablet
5
ARROW PHARMACEUTICALS PTY LTD
Australia
5
$286K
ALEMBIC PHARMACEUTIC…
Tablet
6
R.J. CHEMICALS INC
El Salvador
1
$220K
SYNERGENE ACTIVE ING…
Tablet
7
MACLEODS PHARMA USA INC
United States
8
$182K
MACLEODS PHARMACEUTI…
Tablet
8
PHARMACEUTICAL TECHNOLOGYCALLE DESI
Dominican Republic
8
$152K
MEPRO PHARMACEUTICAL…
Tablet
9
ARROW GENERIQUES
France
5
$151K
AUROBINDO PHARMA LTD
Tablet
10
SUNSHINE HEALTHCARE LANKA LTD
Sri Lanka
9
$112K
ZYDUS LIFESCIENCES LTD
Tablet
11
APL SWIFT SERVICES (MALTA) LTD
Malta
17
$111K
AUROBINDO PHARMA LTD
Tablet
12
ZYDUS HEALTHCARE PHILIPPINES INC
Philippines
4
$97K
ZYDUS LIFESCIENCES LTD
Tablet
13
SUN PHARMA EAST AFRICA LTD
Kenya
2
$97K
SUN PHARMACEUTICAL I…
Tablet
14
M/S.SUN PHARMA CANADA INC
Canada
2
$73K
SUN PHARMACEUTICAL I…
Tablet
15
DROGUERIA ANPHAR NICARAGUA, S.A
Nicaragua
1
$56K
MEDICO REMEDIES LTD
Tablet
16
MACLEODS PHARMACEUTICALS SA
South Africa
2
$48K
MACLEODS PHARMACEUTI…
Tablet
17
YUSEN LOGISTICS BENELUX BELGIUM
Belgium
3
$42K
SUN PHARMACEUTICAL I…
Tablet
18
DANANG PHARMACEUTICAL MEDICAL
Vietnam
1
$41K
ZYDUS LIFESCIENCES LTD
19
ELARA PHARMASERVICES LTD
United Kingdom
2
$40K
JUBILANT GENERICS LTD
Tablet
20
HAPHARCO J.S.C. BRANCH
Vietnam
3
$39K
ZYDUS LIFESCIENCES LTD
Tablet
21
HAPHARCO J.S.C. BRANCH.27B NGUYEN D
Vietnam
1
$35K
ZYDUS LIFESCIENCES LTD
Tablet
22
HEUMANN PHARMA GMBH
Germany
1
$33K
MACLEODS PHARMACEUTI…
Tablet
23
BALAXI HEALTHCARE HONDURAS S. DE R
Honduras
2
$30K
BALAXI PHARMACEUTICA…
Tablet
24
SYNOPTIS INDUSTRIAL SP .ZO.O
Poland
4
$28K
MACLEODS PHARMACEUTI…
Tablet
25
RAINBOW TRADE CONCERN PVT LTD
Nepal
1
$28K
INTAS PHARMACEUTICAL…
Tablet
26
AMBICA INTERNATIONAL CORP
Philippines
2
$23K
COOPER PHARMA LTD
Tablet
27
EXPOMED LLC
Kyrgyzstan
2
$19K
CORAL LABORATORIES LTD
Tablet
28
PHARMACEUTICAL TECHNOLOGY
Dominican Republic
1
$18K
MEPRO PHARMACEUTICAL…
Tablet
29
J. KNIPPER & COMPANY
United States
1
$16K
ALEMBIC PHARMACEUTIC…
Tablet
30
ARROW GENERIQUES, 26 AVENUE TONY
France
2
$14K
AUROBINDO PHARMA LTD
Tablet
31
DROGUERIA AVICENNA S.A DE C.V
Honduras
1
$13K
MACLEODS PHARMACEUTI…
Tablet
32
TO THE DIRECTOR OF
Venezuela
2
$9K
SCOTT EDIL PHARMACIA…
Tablet
33
CIMPORTPHARMA S.A
Ecuador
2
$9K
PNEU-PHARMA ( INDIA)
Tablet
34
CONTROLLED MEDICATIONS LTD
Hong Kong
1
$7K
JUBILANT GENERICS LTD
Tablet
35
ANPHAR SA DE CV
Honduras
2
$4K
MEDICO REMEDIES LTD
Tablet
36
LABORATORIOS REMENY, C.A
Venezuela
2
$4K
KWALITY PHARMACEUTIC…
Tablet
37
CASA DE REPRESENTACION MARQUEZ Y K
Venezuela
1
$3K
DOSSMEGT PHARMACEUTI…
Tablet
38
DROGUERIA AVICENNA S .A. DE C.V
Honduras
1
$2K
MACLEODS PHARMACEUTI…
Tablet
39
ZENUFA CONGO SARL
DR Congo
1
$2K
ICON PHARMA
Injection
40
SHAHEED SA
Afghanistan
1
$510.25
ARSON BIOTECH
repsule
41
ANAZ LOGISTICS
Somalia
1
$296.93
BAKER & DAVIS PVT LTD
Injection
42
MEDINOVA PHARMACEUTCAL INC
Philippines
1
$236.97
MACLEODS PHARMACEUTI…
Tablet
43
EMIRATES POST COMPANY
United Arab Emirates
9
$211.71
DERRIC WOOD
Tablet
44
PHILGEN PHARMACEUTICALS INC
Philippines
1
$92.16
CENTURION LABORATORI…
Tablet
45
HEALTH & GLOW PHARMACEUTICALS
Zambia
2
$88.40
PATSONS INTERNATIONAL
Tablet
46
CAREWELL PHARMACY (PTY)LTD
Seychelles
1
$6.64
CHEMSELECT PVT LTD
Tablet
47
ALYONA CHORICH
Russia
3
$3.01
MICRO LABS LTD
Vial, Pack, Tablet
This report covers 184 2025-Q4 Irbesartan shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/irbesartan
Talk to our trade analyst
Need a custom irbesartan report or a deeper dive into any market? Our team is ready.